Abound Wealth Management’s Biogen BIIB Stock Holding History

Abound Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.28K	Sell	15 -11	-42%	-$2.1K	﹤0.01%	671
2026 Q1	$4.72K	Hold	26	–	–	﹤0.01%	739
2025 Q4	$4.53K	Buy	26 +4	+18%	+$653	﹤0.01%	695
2025 Q3	$3.09K	Hold	22	–	–	﹤0.01%	740
2025 Q2	$2.76K	Buy	22 +4	+22%	+$498	﹤0.01%	700
2025 Q1	$2.46K	Sell	18 -3	-14%	-$429	﹤0.01%	668
2024 Q4	$3.21K	Hold	21	–	–	﹤0.01%	613
2024 Q3	$4.07K	Hold	21	–	–	﹤0.01%	585
2024 Q2	$4.87K	Sell	21 -2	-9%	-$435	﹤0.01%	506
2024 Q1	$4.96K	Buy	23 +6	+35%	+$1.41K	﹤0.01%	523
2023 Q4	$4.4K	Sell	17 -8	-32%	-$1.97K	﹤0.01%	539
2023 Q3	$6.43K	Sell	25 -4	-14%	-$1.07K	﹤0.01%	411
2023 Q2	$8.26K	Buy	29 +4	+16%	+$1.19K	﹤0.01%	379
2023 Q1	$6.95K	Buy	25 +9	+56%	+$2.49K	﹤0.01%	341
2022 Q4	$4.43K	Buy	16 +9	+129%	+$2.54K	﹤0.01%	372
2022 Q3	$1.87K	Buy	+7	New	+$1.49K	﹤0.01%	493

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Abound Wealth Management's BIIB Position: Q2 2026 in Review

Abound Wealth Management reduced its Biogen (BIIB) stake by 42% in Q2 2026, selling an estimated $2.1K and leaving 15 shares worth $3.28K. The position accounts for ﹤0.01% of the portfolio, ranked #671.

Abound Wealth Management first reported a position in BIIB in Q3 2022 and has held it in 16 quarters since. The position peaked at $8.26K in Q2 2023. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Abound Wealth Management held 15 shares of Biogen worth $3.28K as of Q2 2026.
Abound Wealth Management sold 11 Biogen shares in Q2 2026, an estimated $2.1K.
Biogen made up ﹤0.01% of Abound Wealth Management's portfolio in Q2 2026, its #671 holding.
Abound Wealth Management first reported a position in Biogen in Q3 2022 and has held it in 16 quarters since.
Abound Wealth Management's Biogen position peaked at $8.26K in Q2 2023.
1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.